Location: Home
  • search
  • go
  • Relate News
  • 5/25/2020Healthcare-related Highlights: Premier Li Delivers 2020 Government Wor...
  • 5/25/2020Recent Executive Moves
  • 5/22/2020Data Snapshot and Outlook of the Chinese Chronic Disease Market
  • 5/22/2020Apollomics Announces Initiation of SPARTA P2 Trial for c-MET Inhibitor...
  • 5/22/2020Affibody Signs EUR208M Deal To Market Autoimmune Drug in China
  • 5/22/2020I-Mab and Genexine Announce Chinese Approval for P2 Trial of TJ107/HyL...
  • 5/22/2020BeiGene and Medison Announce Distribution Deal and Acceptance of NDA f...
  • 5/21/2020CanSino and Precision NanoSystems Announce Collaboration to Co-Develop...
  • 5/20/2020CDE Solicits Public Comments for Clinical Research Guidelines for Epra...
  • 5/20/2020Asia Pacific Biopharma Contract Manufacturing Market Rise 8.8% CAGR to...
  • 5/20/2020Trump Is Investing Millions to Bring Drug Making Back to US From India...
  • 5/19/2020Tyvyt Combined with Gemzar and Platinum Chemotherapy Met Endpoint in P...
  • 5/19/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • 5/19/2020Innovent and MD Anderson Announce Partnership to Develop anti-PD-1 The...
  • 5/19/2020Qingdao Primedicine and Primary Peptides Enter Exclusive China Partner...
  • 5/18/2020GSK Granted Clinical Trial Approval of ICOS mAb with Keytruda for HNSC...
  • 5/15/2020Recent Executive Moves
  • 5/15/2020Kangmei Pharma Fined $84,600 for $12.6B Fraud
  • 5/14/2020Consumption Patterns of Chinese Public Medical Institution Drug Sales ...
  • 5/14/2020Snapshot of BMI System Financial Performance in Q1/2020
  • 5/14/2020China's Role in The Global Biotechnology Sector and Implications for U...
  • 5/14/2020Novocure's Optune Approved for Glioblastoma in China
  • 5/14/2020Innovent/Eli Lilly Announce Positive Outcome of TYVYT (Sintilimab Inj)...
  • 5/14/2020Leading Performance Review of Chinese CRO and CDMO/CMO Sector in 2019
  • 5/14/2020Takeda's ADC Drug Adcetris Approved for Marketing in China
  • 5/13/2020CDE Solicits Comments on Draft Guideline on Adaptive Designs for Clini...
  • 5/13/2020CDE Issues Notice on Adjustment of the Submission Time and Form of Imp...
  • 5/12/2020NHSA Issues Notice Requiring BMI Agencies to Settle with Designated Pr...
  • 5/12/2020Herbalmax to Invest $150M in Biotech Project in Wuxi
  • 5/11/2020Simcere Pharma and Primary Peptides Inc. Announce Exclusive China Part...
  • Page:93/334 Total number of articles:9993: [First][<<] [91] [92] [93] [94] [95] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group